572 related articles for article (PubMed ID: 30673077)
21. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
[TBL] [Abstract][Full Text] [Related]
22. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
23. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
24. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.
Lanz J; Bouwes Bavinck JN; Westhuis M; Quint KD; Harwood CA; Nasir S; Van-de-Velde V; Proby CM; Ferrándiz C; Genders RE; Del Marmol V; Forchetti G; Hafner J; Vital DG; Hofbauer GFL
JAMA Dermatol; 2019 Jan; 155(1):66-71. PubMed ID: 30516812
[TBL] [Abstract][Full Text] [Related]
25. Impact of human leukocyte antigen mismatch on lung transplant outcome.
Yamada Y; Langner T; Inci I; Benden C; Schuurmans M; Weder W; Jungraithmayr W
Interact Cardiovasc Thorac Surg; 2018 May; 26(5):859-864. PubMed ID: 29300898
[TBL] [Abstract][Full Text] [Related]
26. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
[TBL] [Abstract][Full Text] [Related]
27. Human Leukocyte Antigen-Based Risk Stratification in Heart Transplant Recipients-Implications for Targeted Surveillance.
Nilsson J; Ansari D; Ohlsson M; Höglund P; Liedberg AS; Smith JG; Nugues P; Andersson B
J Am Heart Assoc; 2019 Aug; 8(15):e011124. PubMed ID: 31339067
[TBL] [Abstract][Full Text] [Related]
28. External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort.
Gómez-Tomás Á; Bouwes Bavinck JN; Genders R; González-Cruz C; de Jong E; Arron S; García-Patos V; Ferrándiz-Pulido C
JAMA Dermatol; 2023 Jan; 159(1):29-36. PubMed ID: 36416811
[TBL] [Abstract][Full Text] [Related]
29. The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome‒free survival among sensitized lung transplant recipients.
Courtwright AM; Kamoun M; Kearns J; Diamond JM; Golberg HJ
J Heart Lung Transplant; 2020 Dec; 39(12):1455-1462. PubMed ID: 33071182
[TBL] [Abstract][Full Text] [Related]
30. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
Kang W; Sampaio MS; Huang E; Bunnapradist S
Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
[TBL] [Abstract][Full Text] [Related]
31. HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation.
Hussain SK; Makgoeng SB; Everly MJ; Goodman MT; Martínez-Maza O; Morton LM; Clarke CA; Lynch CF; Snyder J; Israni A; Kasiske BL; Engels EA
Transplantation; 2016 Nov; 100(11):2453-2460. PubMed ID: 26636741
[TBL] [Abstract][Full Text] [Related]
32. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
Bunnapradist S; Hong A; Lee B; Takemoto SK
Transplant Proc; 2005 Mar; 37(2):886-8. PubMed ID: 15848565
[TBL] [Abstract][Full Text] [Related]
33. Role of standard HLA mismatch in modifying associations between non-pharmacologic risk factors and solid organ malignancy after kidney transplantation.
Santos AH; Mehta R; Ibrahim H; Leghrouz MA; Alquadan K; Belal A; Lee JJ; Wen X
Transpl Immunol; 2023 Oct; 80():101885. PubMed ID: 37414265
[TBL] [Abstract][Full Text] [Related]
34. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
36. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
37. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study.
Martinez JC; Otley CC; Stasko T; Euvrard S; Brown C; Schanbacher CF; Weaver AL;
Arch Dermatol; 2003 Mar; 139(3):301-6. PubMed ID: 12622621
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
39. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
40. A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity.
Wiebe C; Kosmoliaptsis V; Pochinco D; Taylor CJ; Nickerson P
Transplantation; 2018 Aug; 102(8):1338-1343. PubMed ID: 29443827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
